A group of scientists in Great Britain have discovered a protein, which is directly involved in the resistance of the organism against medicines for breast cancer. In the future, this research may offer a new “aim” concerning the new type of medical cures for this specific disease. Researchers at the Imperial College of London, with Georgios Giamas, head of the Surgery and Cancer Department, experimented on mice and discovered that if they blocked the production of LMTK3 protein with genetic techniques, they could minimize the cancer tumor. The study was published in the medical journal “Nature Medicine”. Now, scientists are looking for new medicines that could have a correspondent result on humans. Dr. Georgios Giamas studied at the Department of Biology at the University of Athens and got his PhD in Human Biology from the University of Ulm. Today, he works as a post-PhD researcher at Imperial College of London, where he is mostly interested in the biology of breast cancer.